Zobrazeno 1 - 10
of 33
pro vyhledávání: '"James J. Saller"'
Autor:
Daryoush Saeed-Vafa, Kyriakos Chatzopoulos, Juan Hernandez-Prera, Pedro Cano, James J. Saller, Julie E. Hallanger Johnson, Bryan McIver, Theresa A. Boyle
Publikováno v:
Frontiers in Genetics, Vol 15 (2024)
Introduction: Medullary thyroid carcinoma (MTC) is an aggressive cancer that is often caused by driver mutations in RET. Splice site variants (SSV) reflect changes in mRNA processing, which may alter protein function. RET SSVs have been described in
Externí odkaz:
https://doaj.org/article/43f3651c022f4709b71eca41e706cfce
Autor:
Yun Pyo Kang, Aimee Falzone, Min Liu, Paloma González-Sánchez, Bo-Hyun Choi, Jonathan L. Coloff, James J. Saller, Florian A. Karreth, Gina M. DeNicola
Publikováno v:
Cancer & Metabolism, Vol 8, Iss 1, Pp 1-13 (2020)
Abstract Background d-3-phosphoglycerate dehydrogenase (PHGDH), which encodes the first enzyme in serine biosynthesis, is overexpressed in human cancers and has been proposed as a drug target. However, whether PHGDH is critical for the proliferation
Externí odkaz:
https://doaj.org/article/10e50bc8495c4a54bb2a375c109217bd
Autor:
Theresa A. Boyle, Gwendolyn P. Quinn, Matthew B. Schabath, Teresita Muñoz‐Antonia, James J. Saller, Luisa F. Duarte, Laura S. Hair, Jamie K. Teer, Derek Y. Chiang, Rebecca Leary, Connie C. Wong, Alexander Savchenko, Angad P. Singh, LaSalette Charette, Kate Mendell, Gullu Gorgun, Scott J. Antonia, Alberto A. Chiappori, Benjamin C. Creelan, Jhanelle E. Gray, Eric B. Haura
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 225-237 (2020)
Abstract Background For the advancement of cancer research, the collection of tissue specimens from drug‐resistant tumors after targeted therapy is crucial. Although patients with lung cancer are often provided targeted therapy, post‐therapy spec
Externí odkaz:
https://doaj.org/article/82ae3eb5e1ff40e2b1ca8ba0ac5ee571
Autor:
Paul A. Stewart, Eric A. Welsh, Robbert J. C. Slebos, Bin Fang, Victoria Izumi, Matthew Chambers, Guolin Zhang, Ling Cen, Fredrik Pettersson, Yonghong Zhang, Zhihua Chen, Chia-Ho Cheng, Ram Thapa, Zachary Thompson, Katherine M. Fellows, Jewel M. Francis, James J. Saller, Tania Mesa, Chaomei Zhang, Sean Yoder, Gina M. DeNicola, Amer A. Beg, Theresa A. Boyle, Jamie K. Teer, Yian Ann Chen, John M. Koomen, Steven A. Eschrich, Eric B. Haura
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-17 (2019)
Squamous cell lung cancer has dismal prognosis due to the dearth of effective treatments. Here, the authors perform an integrated proteogenomic analysis of the disease, revealing three proteomics-based subtypes and suggesting potential therapeutic op
Externí odkaz:
https://doaj.org/article/841bd6d6165d4e9f8532ae0a3ce6a908
Autor:
Eric B. Haura, John M. Koomen, Aaron S. Meyer, Theresa A. Boyle, Eric A. Welsh, Paul A. Stewart, Bin Fang, Kiah Bowers, Fumi Kinose, Benjamin S. Meyer, Marc Creixell, Shruti Agarwal, Guolin Zhang, Matthew A. Smith, James J. Saller, Emma Adhikari, Mia Stroud, Sina Hosseinian, Anurima Majumder
Supplementary Figure from Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24ac75589010fb268fb647b52f21f8ac
https://doi.org/10.1158/1541-7786.22527645
https://doi.org/10.1158/1541-7786.22527645
Autor:
Eric B. Haura, John M. Koomen, Aaron S. Meyer, Theresa A. Boyle, Eric A. Welsh, Paul A. Stewart, Bin Fang, Kiah Bowers, Fumi Kinose, Benjamin S. Meyer, Marc Creixell, Shruti Agarwal, Guolin Zhang, Matthew A. Smith, James J. Saller, Emma Adhikari, Mia Stroud, Sina Hosseinian, Anurima Majumder
Supplementary Table from Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19b116c1823d2cbb8b239010da1bf43a
https://doi.org/10.1158/1541-7786.22527618.v1
https://doi.org/10.1158/1541-7786.22527618.v1
Autor:
Eric B. Haura, John M. Koomen, Aaron S. Meyer, Theresa A. Boyle, Eric A. Welsh, Paul A. Stewart, Bin Fang, Kiah Bowers, Fumi Kinose, Benjamin S. Meyer, Marc Creixell, Shruti Agarwal, Guolin Zhang, Matthew A. Smith, James J. Saller, Emma Adhikari, Mia Stroud, Sina Hosseinian, Anurima Majumder
Supplementary Data from Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a46e0c1691b3b737ecf1a8d521bd899
https://doi.org/10.1158/1541-7786.22527648.v1
https://doi.org/10.1158/1541-7786.22527648.v1
Autor:
Amer A. Beg, Dung-Tsa Chen, Theresa A. Boyle, Ram Thapa, Kristen Goas, Nishan Tchekmedyian, Zhihua Chen, James J. Saller, Wenjie Dai, Hong Zheng, Michael Shafique, Scott J. Antonia, Ben Creelan, Eric B. Haura, Tawee Tanvetyanon, Andreas Saltos, Jhanelle E. Gray
Patient characteristics per PD-L1 stratification subgroups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57397c45cb122f9b741ed93cd8b3d6f6
https://doi.org/10.1158/1078-0432.22471743.v1
https://doi.org/10.1158/1078-0432.22471743.v1
Autor:
Amer A. Beg, Dung-Tsa Chen, Theresa A. Boyle, Ram Thapa, Kristen Goas, Nishan Tchekmedyian, Zhihua Chen, James J. Saller, Wenjie Dai, Hong Zheng, Michael Shafique, Scott J. Antonia, Ben Creelan, Eric B. Haura, Tawee Tanvetyanon, Andreas Saltos, Jhanelle E. Gray
Percentage of granulocytic (PMN) and monocytic MDSC in total PBMC of NSCLC trial participants.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9255e99dcaf063a811238127b6642ffe
https://doi.org/10.1158/1078-0432.22471755
https://doi.org/10.1158/1078-0432.22471755
Autor:
Amer A. Beg, Dung-Tsa Chen, Theresa A. Boyle, Ram Thapa, Kristen Goas, Nishan Tchekmedyian, Zhihua Chen, James J. Saller, Wenjie Dai, Hong Zheng, Michael Shafique, Scott J. Antonia, Ben Creelan, Eric B. Haura, Tawee Tanvetyanon, Andreas Saltos, Jhanelle E. Gray
Purpose:Histone deacetylase inhibitors (HDACi) enhance tumor immunogenicity through several mechanisms and may improve response to immune checkpoint inhibitors (ICIs). In a phase I/Ib trial, we tested the oral HDACi vorinostat combined with the progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18ce3900a19a4e1a7edf5e068cc1744b
https://doi.org/10.1158/1078-0432.c.6527991.v1
https://doi.org/10.1158/1078-0432.c.6527991.v1